Welcome to our dedicated page for Banco Bradesco SEC filings (Ticker: BBD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Banco Bradesco S.A. (BBD) SEC filings provide detailed, official information on the Brazilian bank’s operations, governance and capital structure for holders of its American Depositary Shares. As a foreign private issuer, Banco Bradesco files annual reports on Form 20-F and furnishes current information on Form 6-K, making these documents a primary source for understanding the BBD investment case.
On this page, investors can review Form 6-K current reports that cover a wide range of topics. These include economic and financial analysis reports with managerial commentary on recurring net income, net interest income, loan portfolio composition, delinquency indicators, fee and commission income, insurance results and capital ratios. The filings also discuss transformation initiatives, footprint adjustments and sustainable business financing targets.
Another key group of filings relates to interest on shareholders’ equity and other capital distributions. Banco Bradesco S.A. discloses its systematic monthly payment schedule, as well as interim and supplementary interest on shareholders’ equity, specifying total amounts and per-share values for common and preferred shares, tax treatment and the role of these payments in mandatory dividends. These documents help investors understand how the bank returns capital to shareholders of both local shares and BBD ADSs.
The filings also contain consolidated forms on insider and controlling shareholder positions. These tables show opening balances, month movements and closing balances of common and non-voting shares held by the controller, board of directors, executive officers, audit committee, technical and advisory agencies, treasury and controlled entities. They detail buy, sell and securities lending operations, offering transparency on insider activity.
Additional 6-K reports address related-party transactions and strategic investments, such as the renewal of an intermediation services agreement with Cielo S.A. and hospital investment agreements through Atlântica Hospitais e Participações S.A. An annual calendar of corporate events sets out planned dates for financial statement releases, quarterly information, shareholder meetings and analyst presentations.
Stock Titan’s platform surfaces these SEC filings in real time from EDGAR and adds AI-powered summaries to highlight the most relevant sections, whether you are looking at a lengthy financial analysis, a schedule of interest on shareholders’ equity, or detailed insider shareholding tables. This helps investors quickly interpret Form 6-K and Form 20-F disclosures for Banco Bradesco S.A. without reading every page.
Banco Bradesco S.A. is calling an extraordinary general meeting for March 31, 2026 to approve the partial spin-off of its wholly owned subsidiary Bradseg Participações S.A., with spun-off net assets of R$ 16,136,310,439.65 being absorbed by Bradesco. The spun-off portion consists of all shares of Bradesco Gestão de Saúde S.A. and Bradseg’s stake in Odontoprev S.A., as the first step in a broader transaction to consolidate Bradesco’s healthcare businesses under Odontoprev. The spin-off will not increase Bradesco’s capital or issue new shares, so there is no shareholder dilution or withdrawal right. Management highlights expected administrative efficiency and a more integrated health and dental offering, with estimated implementation costs around R$ 300,000.00.
Banco Bradesco S.A. called an Extraordinary General Meeting for March 31, 2026 at 4:00 p.m., to be held exclusively in digital format. Shareholders will vote on approving the partial spin-off of Bradseg Participações S.A., with the spun-off net assets absorbed by Bradesco.
This spin-off is part of a broader business combination involving Bradesco Gestão de Saúde S.A. and Odontoprev S.A., with the goal of unifying Bradesco’s health-segment equity interests in Odontoprev. After all stages are completed, Odontoprev is expected to consolidate Bradesco’s healthcare ecosystem, simplifying the corporate structure and potentially improving administrative efficiency.
Banco Bradesco S.A. is restructuring its healthcare businesses by consolidating them under Odontoprev S.A., which will be renamed Bradsaúde S.A.. Bradseg will be partially spun off so that Bradesco directly holds shares of Odontoprev and Bradesco Gestão de Saúde (BGS), and Odontoprev will merge the shares of BGS, making BGS its wholly owned subsidiary. Bradesco will receive 2,378,374,445 new Odontoprev shares in exchange for all BGS shares, based on an exchange ratio of 0.17998067486 Odontoprev share per BGS share. After the transaction, Bradesco will own 91.35% of Odontoprev’s total and voting capital and current Odontoprev shareholders will hold 8.65%, excluding treasury shares and any withdrawal effects. Odontoprev’s dental operations and related assets will be contributed to Mediservice, and Odontoprev/Bradsaúde will act solely as a holding company for Bradesco’s healthcare businesses. The companies highlight expected commercial synergies, broader healthcare scope, and potential Basel ratio benefits for Bradesco, while noting that the spin-off itself does not change Bradesco’s share capital and does not create withdrawal rights for Bradesco or Bradseg shareholders.
Banco Bradesco S.A. responded to a request from the Brazilian securities regulator about media comments on its agribusiness growth targets. The article cited a projection of 15%–20% growth in the direct agribusiness portfolio in 2026, on a base then estimated at R$ 120 billion.
Bradesco explains that these rural credit projections are already included in its previously released guidance, so it did not see a need to publish a separate material fact. The bank emphasizes that these projections are not guarantees of future performance and are subject to risks and uncertainties.
It also cites applicable Brazilian regulations, including Resolution No. 44/2021, and reiterates that any material facts or changes in projections will be disclosed to the market in a timely manner through the appropriate channels.
Banco Bradesco S.A. filed a report summarizing January 2026 share positions and trades by management, their families, treasury, and numerous controlled and related companies. Most groups, including the controlling shareholder group, board of directors, audit committee, technical bodies, treasury, and affiliates, showed no operations in securities or derivatives during the month and unchanged balances.
The only reported trades came from the Board of Executive Officers, which executed sales of non-voting shares totaling 41,869 shares for R$ 771,813.04, plus a securities lending credit of 3,942 non-voting shares for R$ 72,059.76. After these movements, this group held 68,136 common shares and 10,767,054 non-voting shares. The controller group maintained holdings of 3,811,582,439 common shares and 121,067,106 non-voting shares with unchanged participation percentages.
Banco Bradesco is calling special and annual shareholders’ meetings, to be held exclusively digitally on March 10, 2026, to vote on key capital, governance and payout decisions. The board proposes increasing share capital by R$6.67 billion, from R$87.1 billion to R$93.77 billion, through capitalization of the Legal Reserve, without issuing new shares or bringing in fresh cash.
Shareholders will also vote on updating the bylaws to allow profit sharing for management, with the Board of Directors empowered to set amounts within Brazilian legal limits. For 2025, Bradesco reports net income of R$24.55 billion and proposes allocating R$1.06 billion to the Legal Reserve, R$5.67 billion to the Statutory Reserve and R$14.50 billion as interest on shareholders’ equity. Of this payout, R$7.60 billion has already been paid and R$6.90 billion is scheduled for payment in 2026, corresponding to about 61% of adjusted net income and satisfying the 30% mandatory dividend rule.
Banco Bradesco S.A. is calling combined special and annual shareholders’ meetings for March 10, 2026, held exclusively digitally, to vote on key capital, governance and payout decisions.
Shareholders will consider a R$6.67 billion increase in share capital, from R$87.1 billion to R$93.77 billion, by capitalizing part of the legal profit reserve with no new shares or cash raised. They will also vote on a bylaw change to allow profit sharing for management, with the Board of Directors empowered to set amounts within Brazilian legal limits. For 2025, net income of R$24.55 billion is proposed to be allocated to R$1.06 billion for the legal reserve, R$5.67 billion to the statutory reserve and R$14.50 billion as interest on shareholders’ equity, of which R$7.60 billion has been paid and R$6.90 billion will be paid in 2026, corresponding to about 61% of adjusted net income. The meetings will also vote on approval of 2025 financial statements, election of Board and Fiscal Council members, and 2026 compensation for management and the Fiscal Council.